GHK-Cu exerts its effects primarily through gene expression modulation, influencing approximately 31% of the human genome by upregulating genes involved in antioxidant responses, DNA repair, protein metabolism, and cellular growth while downregulating inflammatory mediators, fibrinogen synthesis, and pathological processes including cancer metastasis
These effects, if they translate to clinically meaningful changes in human autoimmune patients, would complement rather than replace targeted biologic therapy
Successful pairings in pilot studies and case reports have been mitochondrial-supporting peptides and antioxidant peptides, and small immunomodulatory peptides with antioxidants to combat inflammatory reactive oxygen species
The protocol starts with a scan from a device that diagnoses texture, tone, and trouble spots